NSEInvestor Presentation3d ago · 6 Nov 2026, 12:01 pm

Investor Presentation

IG Petrochemicals Limited · IGPL

✦ AI Summary▲ PositiveResults

IG Petrochemicals Limited has informed the Exchange about Investor Presentation, enclosing an Investor Presentation on the financial results of the Company for the quarter and half year ended 30th September, 2026. The presentation highlights the Company's highest ever Q2 & H1 FY27 revenue, EBITDA, and PAT, with significant growth in realizations across all products. The Board declared an interim dividend @100% (Rs. 10 per equity share) for FY27.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IG Petrochemicals Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

IGPL_06112026120059_SEInvestorPresentation_06112026.pdf

pdf

Download →
View document text
6th November, 2026 BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza 1st Floor, P J Towers Bandra Kurla Complex Dalal Street Bandra (East) Mumbai - 400 001 Mumbai – 400 051 Scrip Code: 500199 Scrip Code: IGPL Sub: Investor Presentation – Regulation 30 Dear Sir, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith an Investor Presentation on the financial results of the Company for the quarter and half year ended 30th September, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For I G Petrochemicals Limited Sudhir R Singh Company Secretary Encl: As Above From Scale to Integration Investor Presentation – November 2026 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by I G Petrochemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Index Sr No. Details 1 Q2 & H1 FY27 Performance 2 Company Overview 3 Product Highlights 4 Growth Strategies 5 Value Proposition 6 Experienced Board 7 Historical Financials Highest Ever Q2 & H1 FY27 Revenue Revenue^ (Rs. Crs) EBITDA (Rs. Crs) PAT (Rs. Crs) Margin 5.8% 18.8% 4.2% 19.0% 0.3% 11.7% -0.7% 11.6% 770 1,395 144 264 90 161 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Key Highlights • Total revenue for Q2FY27 grew by 63% on YoY basis at Rs. 770 Crs, and at Rs. 1,395 Crs for H1FY27, up 46% YoY, led by improved realizations across all products. • EBITDA grew significantly for Q2 FY27 to Rs. 144 crore and Rs. 264 crore in H1 FY27, with margins of 18.8% and 19.0%, respectively. • PAT increased to Rs. 90 crore for Q2FY27 and ₹161 crore in H1 FY27. • Revenue from the Non-Phthalic business also increased to Rs. 68 Crs for Q2FY27, and Rs. 117 Crs for H1FY27. • Revenue from the Export market contributed ~4% for Q2FY27. • Plasticizer plant commenced production on 30th September 2026 • India Ratings affirmed ‘IND AA-/Stable/IND A1+’ on existing bank loan facilities and assigned the same to additional loan facilities. • The Board declared an interim dividend @100% (Rs. 10 per equity share) for FY27. ^ Includes Other Income 4 Profit & Loss Statement Particulars (Rs. Crs) Q2 FY27 Q2 FY26 Y-o-Y H1 FY27 H1 FY26 Y-o-Y Total Revenue^ 769.7 471.6 63.2% 1,394.7 952.5 46.4% Raw Material 537.3 357.4 954.9 736.2 Employee Expenses 27.8 24.0 58.2 47.8 Other Expenses 60.2 62.9 117.3 128.2 EBITDA 144.4 27.3 428.1% 264.4 40.4 554.6% EBITDA Margin (%) 18.8% 5.8% 19.0% 4.2% Depreciation 15.5 15.2 31.0 30.8 EBIT 129.0 12.2 nm 233.4 9.6 nm Finance Cost 8.1 10.2 17.6 18.4 Profit BeforeTax 120.9 2.0 nm 215.8 -8.8 nm Tax 30.5 0.6 54.4 -2.0 Profit After Tax 90.4 1.4 nm 161.4 -6.8 nm PAT Margin (%) 11.7% 0.3% 11.6% - EPS (in Rs.) 29.35 0.46 52.39 -2.21 On Standalone Basis ^ Includes Other Income 5 Balance Sheet Particulars (Rs. Crs) Sep-26 Mar-26 Particulars (Rs. Crs) Sep-26 Mar-26 Equity Non-Current assets Equity Share Capital 30.8 30.8 Property, Plant and Equipment 1,114.2 911.3 Other Equity 1,436.0 1,289.7 Capital Work-In-Progress 34.7 173.1 Total Equity 1,466.8 1,320.5 Goodwill 2.0 2.0 Other Intangible Assets 0.7 0.6 Non-Current Liabilities Right use of assets 43.5 44.5 Financial Liabilities Investment Property 0.4 0.4 Borrowings 128.1 147.2 Financial Assets Lease Liabilities 4.0 4.7 Investments 129.5 123.1 Trade Payables 55.1 55.1 Loans 40.0 40.0 Other Liabilities 0.0 0.0 Other Financial Assets 4.6 4.6 Provisions 7.9 8.4 Non-Current Tax Assets - 12.9 Deferred Tax Liabilities (Net) 112.1 105.3 Other Non-Current Assets 12.7 22.1 Total Non-Current Liabilities 307.3 320.7 Total Non-Current Assets 1,382.5 1,334.7 Current Liabilities Current Assets Financial Liabilities Inventories 184.9 206.9 Financial Assets Borrowings 95.0 130.7 Investments 74.9 72.5 Trade Payables 315.6 387.0 Trade Receivables 386.3 350.3 Other Financial Liabilities 65.2 34.1 Cash and Cash Equivalents 1.4 0.4 Other Current Liabilities 15.6 14.0 Bank Balances 167.7 159.0 Provisions 1.5 1.5 Loans 13.9 14.3 Lease Liabilities 1.3 1.3 Other Financial Assets 34.8 36.8 Other Current Liabilities (net) 1.2 - Other Current Assets 23.1 35.0 Total Current Liabilities 495.3 568.6 Total Current Assets 887.0 875.1 Total Equity and Liabilities 2,269.4 2,209.8 Total Assets 2,269.4 2,209.8 On Standalone Basis 6 Cash Flow Statement Particulars (Rs. Crs) Sep-26 Sep-25 Net Profit Before Tax 215.8 -8.8 Adjustments for: Non-Cash Items / Other Investment or Financial Items 39.7 63.4 Operating profit before working capital changes 255.5 54.6 Changes in working capital -47.7 -89.5 Cash generated from Operations 207.8 -34.9 Direct taxes paid (net of refund) -33.6 -4.0 Net Cash from Operating Activities 174.2 -38.9 Net Cash from Investing Activities -89.7 -3.9 Net Cash from Financing Activities -48.6 -36.9 Net Decrease in Cash and Cash equivalents 35.9 -79.6 Add: Cash & Cash equivalents at the beginning of the period -50.2 15.0 Cash & Cash equivalents at the end of the period -14.3 -64.7 Company Snapshot India’s only Incorporated in 1988 Maleic Anhydride* Manufacturer World’s Largest PAN* Manufacturer at Single Location ~ 50% Domestic Market Share of PAN* India’s Largest Phthalic Anhydride Manufacturer 120+ Clients Current Products: Phthalic Anhydride, 20+ End User Industries Served Maleic Anhydride, Benzoic Acid, Di-ethyl Phthalate and Advance Plasticizers ISO Certified Lowest Cost Producer of PAN* 9001:2015 14001:2015 *PAN - Phthalic Anhydride, MAN - Maleic Anhydride Vision & Mission ISO 9001:2015 (Quality) and ISO 14001:2015 (Environment) certified across the complex. Vision To be a well-diversified chemicals company with a leadership position in Phthalic Anhydride Industry Process safety management and 5S standards embedded in daily plant operations. Mission CSR focus: Skill development, Education infrastructure, Environment sustainability and Healthcare. To [Showing first 8,000 characters — download PDF for full document]